Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Activated recombinant factor VII may improve bleeding control in cirrhosis

July 10, 2003

BMS researchers present new compounds with factor VIIa/IMPDH-inhibitory activity

July 8, 2003

New thrombin inhibitors prepared and tested by U. of Ljubljana and LEK researchers

July 2, 2003

Nuvelo initiates phase II testing with alfimeprase in acute peripheral arterial occlusion

July 1, 2003

New factor Xa inhibitors and their use covered by Warner-Lambert patent

June 30, 2003

New antiplatelet agent of fungal origin identified by Aventis

June 23, 2003

Arixtra approved for extended use

June 23, 2003

Novel factor Xa inhibitors in early development at GSK

June 18, 2003

Phase III program under way for once-weekly idraparinux

June 17, 2003

Factor Xa inhibitors prepared and tested by Aventis researchers

June 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.